The BioFacture Cell Manufacturing Platform
BioFacture is revolutionizing efficiency and scalability in cell manufacturing—helping scientists accelerate discovery, scale production efficiently, and reduce costs without compromising precision. Our advanced bioreactor platform supports the production of primary cells such as red blood cells (RBCs), neutrophils, and T cells, cell lines such as CHO cells, and infectious organisms such as malaria parasites, enabling research institutions, biotechnology firms, and pharmaceutical companies to streamline cell manufacturing while minimizing time and consumable costs.
Designed for maximum research efficiency, our bioreactor platform allows scientists to grow their bioprocess with their cells by modular fluidic expansion, or to run four or more parallel experiments simultaneously, accelerating discovery, optimizing workflows, and enabling high-throughput cell culture—all while keeping costs down. Whether comparing variables, testing new protocols, or scaling production, BioFacture helps researchers achieve more in less time.
Our modular system streamlines bioprocess scale-up and adapts as your cultures grow. We offer a range of starter configurations designed to fit your needs today and expand with you tomorrow. Contact us for more details, or to inquire about custom configurations.
The 4X100 Bioreactor is ideal for research scale applications. Small volume, interconnected vessels can be operated independently or linked together fluidically.
The 5X500L Bioreactor is ideal for medium-scale research applications. Interconnected vessels can be operated independently or linked together fluidically.
The 4X2.5L Bioreactor is ideal for larger-scale research or clinical applications. Interconnected vessels can be operated independently or linked together fluidically.
BioFacture devices are all controlled by the BioFacture BioDirector software package. All data is banked in a relational database with GMP-compliant structuring and data logging.